相关实验视频
Updated: May 16, 2025

08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.2K
移植后悔的预测因素:一个在HSCT接受者潜在队列中嵌入的病例对照研究
Janae L Kirsch1, James R Cerhan2, William J Hogan3
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Cancer medicine
|April 1, 2025
概括
没有移植前的因素预测血造干细胞移植 (HSCT) 后的遗憾. 一年内移植结果较差与遗憾有关,突出显示了移植后健康状况对患者满意度的重要性.
科学领域:
- 血液学 血液学 血液学
- 移植医学 移植医学 移植医学
- 心理学 心理学 心理学
背景情况:
- 造血干细胞移植 (HSCT) 是一种拯救生命的手术,对患者的健康有潜在的长期影响.
- 了解影响患者满意度的因素,如移植后悔,对于改善护理和结果至关重要.
- 以前的研究已经探索了移植前预测因素,但移植后结果与遗憾的关联需要进一步调查.
研究的目的:
- 确定与未来移植遗憾相关的血造前干细胞移植 (HSCT) 人口,疾病和心理因素.
- 为了确定与移植遗憾相关的HSCT后变量.
- 为旨在减轻移植后悔和提高患者移植后生活质量的干预措施提供信息.
主要方法:
- 一项前性队列研究,涉及从2008年6月到2013年10月的HSCT候选人.
- 参与者完成了HSCT前和HSCT后1年的标准化调查.
- 匹配的病例对照分析比较了遗憾 (病例) 和没有遗憾 (对照) 的参与者,抽象了HSCT前的心理社会数据并分析了HSCT后的结果.
主要成果:
- 在638名参与者中,8% (49) 报告说在HSCT后一年后悔.
- 没有发现HSCT前的变量可以预测移植后悔.
- 在HSCT后1年没有缓解的患者报告后悔的可能性是3.7倍 (95%CI = 1.37-9.69,p=0.008).
结论:
- 移植前的评估没有确定血造干细胞移植 (HSCT) 的预测因素.
- 在HSCT治疗1年后,较差的健康结果与移植后悔有显著的关联.
- 专注于移植后恢复和缓解状态可能是解决患者遗憾的关键.
相关概念视频
Tissue Transplantation
299
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
299
Bone Marrow Sampling and Transplants
266
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
266
Cell-mediated Immune Responses
66.4K
Overview
66.4K

